Search for " " - Xconomy

Results for “ ”

Entry	Author	Date	Location
Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits	Frank Vinluan	01/22/20	New York
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More	Frank Vinluan	01/17/20	National
Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D	Frank Vinluan	01/15/20	New York
FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data	Frank Vinluan	01/14/20	National
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline	Frank Vinluan	01/14/20	New York
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial	Sarah de Crescenzo	01/13/20	San Francisco
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More	Sarah de Crescenzo	01/10/20	National
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy	Frank Vinluan	01/08/20	San Francisco
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex	Frank Vinluan	01/06/20	New York
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More	Frank Vinluan	01/03/20	National
No More Fish or Fruit: Intrexon Turns SynBio Focus to Human Health	Frank Vinluan	01/02/20	National
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines	Sarah de Crescenzo	12/24/19	National
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More	Sarah de Crescenzo	12/20/19	National
Takeda Pays Turnstone $120M to Start Alliance on Viral Cancer Therapies	Frank Vinluan	12/19/19	New York
Zafgen’s Path Forward Is Reverse Merger With Chondrial Therapeutics	Frank Vinluan	12/18/19	Boston
Orbiting Organoids: Research in Space to Unveil New Neurodegeneration Insight	Melissa Fassbender	12/18/19	National
Axsome’s Depression Drug Meets Phase 3 Goals, FDA Filing Planned	Frank Vinluan	12/16/19	New York
Amarin’s Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk	Sarah de Crescenzo	12/13/19	New York
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More	Frank Vinluan	12/13/19	National
Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink	Frank Vinluan	12/11/19	National
KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test	Frank Vinluan	12/10/19	Boston
Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules	Melissa Fassbender	12/10/19	National
Perceptive Unveils New $210M Fund to Invest in Early-Stage Biotechs	Frank Vinluan	12/10/19	New York
Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule	Frank Vinluan	12/09/19	New York
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More	Sarah de Crescenzo	12/06/19	National
FDA Rejects Enzyvant’s Regenerative Therapy for Rare Immune Disorder	Frank Vinluan	12/05/19	Boston
6 Experimental Alzheimer’s Disease Diagnostics Projects Get Funding Boost	Sarah de Crescenzo	12/04/19	New York
Digital Health Survivors & Innovative Incumbents Must Team Up for True Disruption	Bryony Winn	12/04/19	Raleigh Durham
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck	Frank Vinluan	12/04/19	San Francisco
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal	Frank Vinluan	12/03/19	San Francisco
Page 1 of 293	next page »

Underwriters and Partners

Xpertise: Watch + Learn

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems